1.
肺癌胰腺转移患者临床病理特征与患者预后的单因素分析
The univariate analysis of clinicopathological features and prognosis in lung cancer patients with pancreatic metastasis
| Clinicopathological features | n(%) | Median overall survival (mOS) (months) | P |
| ECOG: Eastern Cooperative Oncology Group. | |||
| Pathological type | 0.001 | ||
| Small cell lung cancer | 26 (78.8) | 10.3 | |
| Non-small cell lung cancer | 7(21.2) | 5.7 | |
| ECOG performance status | 0.154 | ||
| 0-1 | 28 (84.8) | 9.4 | |
| 2-3 | 5 (15.2) | 8 | |
| Diagnose time of pancreatic metastasis | 0.015 | ||
| First visit | 20 (60.6) | 8 | |
| During treatment | 13 (39.4) | 11.05 | |
| Location of pancreatic metastasis | 0.225 | ||
| The head of the pancreas | 14 (42.4) | 9.05 | |
| The body or tail of the pancreas | 19 (57.6) | 9 | |
| Number of pancreatic metastasis | 0.051 | ||
| Single | 22 (66.7) | 9.9 | |
| Multiple | 11 (33.1) | 7 | |